Back to LLY
Compagnie Lombard Odier SCmA → LLY
Compagnie Lombard Odier SCmA LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
18
Latest value
$50M
Q3 2026
Peak value
$254.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.1M |
| Q3 2025 | $163.5M |
| Q3 2025 | $36.1M |
| Q3 2025 | $0 |
| Q4 2025 | $3.5M |
| Q4 2025 | $231.6M |
| Q4 2025 | $40.9M |
| Q4 2025 | $0 |
| Q1 2026 | $5.2M |
| Q1 2026 | $202.7M |
| Q1 2026 | $36.6M |
| Q2 2026 | $6.6M |
| Q2 2026 | $254.6M |
| Q2 2026 | $49.2M |
| Q2 2026 | $0 |
| Q3 2026 | $6.1M |
| Q3 2026 | $250M |
| Q3 2026 | $50M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $50M | 43.2K | — | — |
| Q3 2026 | $250M | 216.1K | — | — |
| Q3 2026 | $6.1M | 5.3K | — | — |
| Q2 2026 | $0 | 0 | — | — |
| Q2 2026 | $49.2M | 41.0K | — | — |
| Q2 2026 | $254.6M | 212.3K | — | — |
| Q2 2026 | $6.6M | 5.5K | — | — |
| Q1 2026 | $36.6M | 39.8K | — | — |
| Q1 2026 | $202.7M | 220.4K | — | — |
| Q1 2026 | $5.2M | 5.6K | — | — |
| Q4 2025 | $0 | 0 | — | — |
| Q4 2025 | $40.9M | 38.1K | — | — |
| Q4 2025 | $231.6M | 215.5K | — | — |
| Q4 2025 | $3.5M | 3.3K | — | — |
| Q3 2025 | $0 | 0 | — | — |
| Q3 2025 | $36.1M | 47.4K | — | — |
| Q3 2025 | $163.5M | 214.3K | — | — |
| Q3 2025 | $2.1M | 2.7K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B